| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/04/2001 | EP1088815A1 Pharmaceutically active sulfonyl amino acid derivatives |
| 04/04/2001 | EP1088552A1 Compositions containing pinolenic acid and its use a health component |
| 04/04/2001 | EP1088100A2 Proteasomal activity |
| 04/04/2001 | EP1088069A1 Angiostatin-binding protein |
| 04/04/2001 | EP1088065A2 Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation |
| 04/04/2001 | EP1087977A1 Thienodipyridine derivatives, production and use thereof |
| 04/04/2001 | EP1087971A1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/04/2001 | EP1087970A1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/04/2001 | EP1087951A1 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 04/04/2001 | EP1087946A1 Aryl alkanoylpyridazines |
| 04/04/2001 | EP1087943A1 Therapeutic biaryl derivatives |
| 04/04/2001 | EP1087937A1 Cyclic hydroxamic acids as metalloproteinase inhibitors |
| 04/04/2001 | EP1087934A1 Aminocyclohexyl ether compounds and uses thereof |
| 04/04/2001 | EP0636127B1 Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
| 04/04/2001 | CN1290266A Benzofuran-4-carboxamides and their therapeutical use |
| 04/04/2001 | CN1290260A Hydroxamic and carboxylic acid derivatives |
| 04/04/2001 | CN1290255A Dihydroxyhexanoic acid derivatives |
| 04/04/2001 | CN1290250A Sulfonylamino derivatives which inhibit matrix-degrading metallopr teinases |
| 04/04/2001 | CN1290165A Benzothiazole Protein tyrosine kinase inhibitors |
| 04/04/2001 | CN1289612A Inflammation-relieving antalgic medicine and its preparing process |
| 04/04/2001 | CN1063956C Liniment tongibing for cold-type arthralgia |
| 04/03/2001 | US6211393 Radicals linked to si are si--o--c, si--s--c or si--n--c type bonds and are hydrolyzable in vivo, forming si--oh bonds that are biologically active especially when in contact with living tissue |
| 04/03/2001 | US6211367 Methods of Synthesing Purine Compounds Having PDE Iv Inhibitory Activity |
| 04/03/2001 | US6211246 Rapidly absorbed liquid compositions |
| 04/03/2001 | US6211243 Methods for treating cold sores with anti-infective compositions |
| 04/03/2001 | US6211234 Substituted phenyl compounds |
| 04/03/2001 | US6211228 Compositions and methods for treating mast-cell mediated conditions |
| 04/03/2001 | US6211222 Substituted indazole derivatives and related compounds |
| 04/03/2001 | US6211210 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use |
| 04/03/2001 | US6211208 2-aminopyridines containing fused ring substituents |
| 04/03/2001 | US6211203 Respiratory system disorders, antiinflammatory agents, enzyme inhibitors |
| 04/03/2001 | US6211201 Multivalent salts of pyridostigmine and related compounds |
| 04/03/2001 | US6211197 Carboxylic acid or tetrazole derivates; analgesics, antipyretics, and antiinflammatory agents; side effect reduction |
| 04/03/2001 | US6211189 Nitric oxide synthase inhibitors; antiinflammatory agents, analgesics |
| 04/03/2001 | US6211182 Histamine h3-antagonists; antiinflammatory agents, antiallergens, antiasthmatics; nervous system, psychological, sleep, and gastrointestinal disorders |
| 04/03/2001 | US6211181 1-Benzenesulfonyl pyrrolidine derivatives as bradykinin receptor antagonists |
| 04/03/2001 | US6211179 Treating sexual disorders, impotency, and menopause; administering purine derivative; nitric oxide synthase substrates |
| 04/03/2001 | US6211171 Administering tricyclic amitriptyline and desipramine to treat neuropathic pain |
| 04/03/2001 | US6211151 Peptides with organo-protective activity, a process for preparation thereof and their use in therapy |
| 04/03/2001 | US6210913 Modulation of integrin-mediated signal transduction |
| 04/03/2001 | US6210890 Human peroxisomal thioesterase |
| 04/03/2001 | US6210670 Cross-reacting monoclonal antibodies specific for E-selectin and P-selectin |
| 04/03/2001 | US6210669 Methods and compositions for immunomodulation |
| 04/03/2001 | CA2224795C Compositions and formulations for producing analgesia and for inhibiting progression of neuropathic pain disorders |
| 04/03/2001 | CA2028287C Benzocycloalkylaminopyridinamines and related compounds, a process and intermediates for their preparation and their use as medicaments |
| 04/03/2001 | CA2023951C N-hydroxy-dibenz¢b,e!oxepin -alkylamines and -alkanoic acid amides, related heterocyclic analogues, a process for their preparation and their use as medicaments |
| 03/29/2001 | WO2001021812A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | WO2001021793A1 p21Cip1 REMEDIES FOR RHEUMATISM |
| 03/29/2001 | WO2001021784A2 Pcna-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | WO2001021660A1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm) |
| 03/29/2001 | WO2001021658A1 32 human secreted proteins |
| 03/29/2001 | WO2001021628A1 A substantially cell membrane impermeable compound and use thereof |
| 03/29/2001 | WO2001021615A1 Benzimidazole derivatives |
| 03/29/2001 | WO2001021600A1 Caspase inhibitor |
| 03/29/2001 | WO2001021591A1 Pyrazole derivatives |
| 03/29/2001 | WO2001021587A2 Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors |
| 03/29/2001 | WO2001021584A1 Tyrosine derivatives |
| 03/29/2001 | WO2001021583A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 03/29/2001 | WO2001021575A1 Anti-inflammatory nitro- and thia- fatty acids |
| 03/29/2001 | WO2001021213A2 Inhibition of secretion from non-neuronal cells |
| 03/29/2001 | WO2001021204A1 Therapeutic uses of m3 polypeptide |
| 03/29/2001 | WO2001021202A2 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells |
| 03/29/2001 | WO2001021191A2 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 03/29/2001 | WO2001021172A1 Anti-cancer nitro- and thia-fatty acids |
| 03/29/2001 | WO2001021171A1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 03/29/2001 | WO2001021170A1 Systems for delivering anti-infective compositions from frangible ampules to treat disordered tissue such as cold sores |
| 03/29/2001 | WO2001021162A2 Treating allergic and inflammatory conditions using desloratadine |
| 03/29/2001 | WO2001021161A2 Use of desloratadine for treating allergic and inflammatory conditions |
| 03/29/2001 | WO2001021156A1 Pharmaceutical chewing gum formulations |
| 03/29/2001 | WO2001021015A1 Compositions for use as food and in cosmetics characterised by their antilipoperoxidative properties |
| 03/29/2001 | WO2001021008A2 Method for increasing pet activity |
| 03/29/2001 | WO2001020981A2 Anti-infective compositions for treating disordered tissue such as cold sores |
| 03/29/2001 | WO2001020969A2 Use of ribose to prevent cramping and soreness in muscles |
| 03/29/2001 | WO2001007067A3 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 03/29/2001 | WO2001007024A3 Paracetamol and drotaverine containing composition |
| 03/29/2001 | WO2000078294A3 Oral administration form for administering a fixed tramadol and diclofenac combination |
| 03/29/2001 | WO2000075139A3 Benzothiazinone and benzoxazinone compounds |
| 03/29/2001 | WO2000073294A3 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides |
| 03/29/2001 | WO2000054761A3 Regulation of phospholipase d activity |
| 03/29/2001 | WO2000047583A8 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 03/29/2001 | WO2000037487A8 αvβ6 INTEGRIN INHIBITORS |
| 03/29/2001 | WO1999050282A3 Peptides for the treatment, prophylaxis, diagnosis and monitoring of autoimmune diseases |
| 03/29/2001 | DE19946289A1 Benzodiazepin-Derivate, deren Herstellung und Anwendung Benzodiazepine derivatives, their production and use |
| 03/29/2001 | DE19945810A1 Substituierte Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted benzimidazole derivatives, processes for their preparation and their use as medicaments |
| 03/29/2001 | DE19945787A1 Arylsulfonamid-substituierte Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Arylsulfonamide-substituted benzimidazole derivatives, processes for their preparation and their use as medicaments |
| 03/29/2001 | CA2847143A1 Inhibition of secretion from non-neuronal cells |
| 03/29/2001 | CA2805979A1 Inhibition of secretiion from non-neuronal cells |
| 03/29/2001 | CA2385552A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | CA2385480A1 32 human secreted proteins |
| 03/29/2001 | CA2385447A1 Pyrazole derivatives |
| 03/29/2001 | CA2385428A1 Novel pcna-associated cell cycle proteins, compositions and methods of use |
| 03/29/2001 | CA2384829A1 Systems for agitated delivery of anti-infective compositions to treat disordered tissue such as cold sores |
| 03/29/2001 | CA2384816A1 Inhibition of abnormal cell growth with corticotropin-releasing hormone analogs |
| 03/29/2001 | CA2383598A1 Therapeutic uses of m3 polypeptide |
| 03/29/2001 | CA2383470A1 Inhibition of secretion from non-neuronal cells |
| 03/29/2001 | CA2383462A1 Therapeutic methods and compounds |
| 03/29/2001 | CA2383214A1 Treating allergic and inflammatory conditions |
| 03/29/2001 | CA2383211A1 Use of desloratadine for treating allergic and inflammatory conditions |
| 03/29/2001 | CA2369515A1 Pharmaceutical chewing gum formulations |
| 03/28/2001 | EP1086950A1 Heterocyclic indole derivatives and mono- or diazaindole derivatives |